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Abstract
To combat COVID-19, clinicians and scien-
tists all need to digest the vast amount of rel-
evant biomedical knowledge in literature to
understand the disease mechanism and the re-
lated biological functions. We have developed
a novel and comprehensive knowledge discov-
ery framework, COVID-KG, which leverages
novel semantic representation and external on-
tologies to represent text and images in the in-
put literature data, and then performs various
extraction components to extract fine-grained
multimedia knowledge elements (entities, re-
lations and events). We then exploit the con-
structed multimedia KGs for question answer-
ing and report generation, using drug repurpos-
ing as a case study. Our framework also pro-
vides detailed contextual sentences, subfigures
and knowledge subgraphs as evidence. All of
the data, KGs, resources and shared services
are publicly available1.
1 Introduction
The COVID-19 pandemic has rapidly changed our
work styles and behaviors in previously unimagin-
able ways, including scientific research. Scientists
across the world have dropped everything to fight
COVID-19. They are racing while collaborating at
unprecedented levels. Practical progress at combat-
ing COVID-19 highly depends on effective search,
analysis, discovery, assessment and extension of
these research results. However, clinicians and sci-
entists are facing two unique barriers on digesting
these research papers.
The first challenge is quantity. Such a bottle-
neck in knowledge access is exacerbated during
a pandemic when the increased investment on rel-
evant research would lead to even faster growth
of literature than usual. For example, till April
28, 2020, at PubMed2 there are 19,443 papers re-
1http://blender.cs.illinois.edu/covid19/
2https://www.ncbi.nlm.nih.gov/pubmed/
Figure 1: The Growing Number of COVID-19 Papers
at PubMed
lated to coronavirus; as of June 13, 2020, there
are 140K+ related papers, nearly 2.7K new papers
per day (see Figure 1). This knowledge bottleneck
causes significant delay in the development of vac-
cines and drugs for COVID-19. More intelligent
knowledge discovery technologies need to be de-
veloped to enable researchers to more quickly and
accurately access and digest relevant knowledge
from literature.
The second challenge is quality due to the
rise and rapid, extensive publications of preprint
manuscripts without pre-publication peer review.
Many research results about coronavirus from dif-
ferent research labs and sources are redundant,
complementary or event conflicting with each other,
while some false information has been promoted at
both formal publication venues and social media
platforms such as Twitter. As a result, some of the
policy responses to the virus, and public perception
of it, have been based on misleading, and at times
erroneous, claims. The isolation of these knowl-
edge resources makes it hard, if not impossible, for
researchers to connect dots that exist in separate
resources to obtain insights. Thus, it is challeng-
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Figure 2: COVID-KG Overview: From Data to Semantics to Knowledge
ing to draw useful conclusions based on previous
research effectively.
Let’s consider drug repurposing as a case study.
Besides the long process of clinical trial and
biomedical experiments, another major cause for
the long process is the complexity of the problem
involved and the difficulty in drug discovery in
general. The current clinical trials for drug re-
purposing mainly rely on symptoms by considering
drugs that can treat diseases with similar symptoms.
However, there are too many drug candidates and
too much misinformation published from multiple
sources. The clinicians and scientists thus need
urgent help to obtain a reliable ranked list of drugs
with detailed evidence. In addition to a ranked list
of drugs, clinicians and scientists also aim to gain
new insights into the underlying molecular cellular
mechanisms on Covid-19, and which pre-existing
conditions may affect the mortality and severity of
this disease.
To tackle these two challenges we propose a new
framework COVID-KG to accelerate scientific dis-
covery and build a bridge between clinicians and bi-
ology scientists, as illustrated in Figure 2. COVID-
KG starts by reading existing papers to build multi-
media knowledge graphs (KGs), in which nodes are
entities/concepts and edges represent relations in-
volving these entities, extracted from both text and
images. Given the KGs enriched with path ranking
and evidence mining, COVID-KG answers natural
language questions effectively. Using drug repur-
posing as a case study, for 11 typical questions that
human experts aim to explore, we integrate our
techniques to generate a comprehensive report for
each candidate drug. Preliminary assessment by
expert clinicians and medical school students show
our generated reports are informative and sound.
2 Multimedia Knowledge Graph
Construction
2.1 Coarse-grained Text Knowledge
Extraction
We apply our state-of-the-art biomedical Informa-
tion Extraction (IE) system (Wang et al., 2019a; Li
et al., 2019; Li and Ji, 2019; Zheng et al., 2014;
Huang et al., 2017) to build knowledge graphs
(KGs), in which nodes are entities/concepts and
edges are the relations and events involving these
entities. This system consists of three components:
(1) coarse-grained entity extraction and entity link-
ing for four entity types: Gene nodes, Disease
nodes, Chemical nodes, and Organism. We follow
the entity ontology defined in the Comparative Tox-
icogenomics Database (CTD) (Davis et al., 2016),
and obtain a Medical Subject Headings (MeSH)
Unique ID for each mention. (2) Based on the
MeSH Unique IDs, we further link all entities to
the CTD and extract 133 subtypes of relations such
as Marker/Mechanism, Therapeutic, and Increase
Expression, and validate them based on document-
level co-occurrence through distant supervision.
These relation types include GeneChemicalInterac-
tion Relationships, ChemicalDisease Associations,
GeneDisease Associations, ChemicalGO Enrich-
ment Associations and ChemicalPathway Enrich-
ment Associations. (3) Event extraction: we extract
Figure 3: Constructed KG Connecting Losartan (candidate drug in COVID-19) and cathepsin L pseudogene 2
(gene related to coronavirus).
13 Event types and the roles of entities involved
in these events, including Gene expression, Tran-
scription, Localization, Protein catabolism, Bind-
ing, Protein modification, Phosphorylation, Ubiq-
uitination, Acetylation, Deacetylation, Regulation,
Positive regulation, Negative regulation. Figure 3
shows an example of the constructed knowledge
graph.
2.2 Fine-grained Text Entity Extraction
Figure 4: Example of Fine-grained Entity Extraction
However, questions from experts often involve
fine-grained knowledge elements, such as Which
animo acids in glycoprotein (a spike protein of
COVID-19) are most related to Glycan (CHEM-
ICAL)?. In order to be able to answer these
questions, We have incorporated 75 fine-grained
entity types automatically annotated by CORD-
NER (Wang et al., 2020d) into the constructed
KG. CORD-NER covers many new entity types
specifically related to the COVID-19 studies (e.g.,
coronaviruses, viral proteins, evolution, materials,
substrates and immune responses), which may ben-
efit research on COVID-19 related virus, spread-
ing mechanisms, and potential vaccines. The en-
tity types come from four sources: (1) 18 gen-
eral entity types from Spacy3 (e.g., person, loca-
tion and organization), (2) 18 biomedical entity
3https://spacy.io/api/annotation#
named-entities
types from SciSpacy4 (e.g., organism, gene, chem-
ical and disease), (3) 127 biomedical entity types
from the UMLS knowledge base5 (e.g., organism,
gene, chemical, disease and biological process),
and (4) 9 new entity types defined by human for
the COVID-19 studies (i.e., coronaviruses, viral
proteins, evolution, materials, substrates, immune
responses, livestock, wildlife and physical science).
CORD-NER reorganizes all the entity types from
the four sources into one entity type hierarchy of
75 fine-grained entity types. CORD-NER relies
on distantly- and weakly-supervised NER meth-
ods (Wang et al., 2019b; Shang et al., 2018), with
no need of expensive human annotation on any ar-
ticles or subcorpus. Its entity annotation quality
surpasses SciSpacy (over 10% higher on the F1
score based on a sample set of documents), a fully
supervised BioNER tool.
Figure 4 shows some examples of the annotation
results on a CORD-19 paper (Zhang et al., 2020).
CORD-NER achieves high quality recognizing the
new entity types. For instance, “SARS-CoV-2” is
recognized as the “CORONAVIRUS” type, “bat”
and “pangolins” are recognized as the “WILDLIFE”
type and “Van der Waals forces” is recognized as
the “PHYSICAL SCIENCE” type.
2.3 Image Processing and Cross-media
Entity Grounding
Figures in biomedical papers contain rich informa-
tion uniquely manifested in the visual modality,
such as molecular structures, microscopic images,
dosage response curves, relational diagrams, and
other visual types. We have developed a visual IE
subsystem to extract the visual information from
figure images to enrich the knowledge graph. We
start by designing a pipeline and automatic tools
shown in Figure 5 to extract figures from papers
in the CORD-19 dataset and segment figures into
close to half million subfigures. Then, we perform
cross-modal entity grounding to ground entities
mentioned in captions or referring text to visual
objects in the subfigures.
One main challenge for figure analysis lies in
the lack of figures stored in separate image files.
Most figures are embedded as part of PDF files of
the papers. We employ Deepfigures (Siegel et al.,
2018) to automatically detect and extract figures
from each PDF document. Each figure is associated
4https://allenai.github.io/scispacy/
5ttps://www.nlm.nih.gov/research/umls/
META3_current_semantic_types.html
Figure 5: System pipeline for automatic figure extrac-
tion and subfigure segmentation.
Fig. The baseplate .p. (A) Isosurface
representa0on of the C3 symmetric
baseplate reconstruc0on at 4.5 σ density
cutoff. The density corresponding to the
Tal trimer is shown in pink, with the rest
of the reconstruc0on in transparent gray.
(B) Central sec0on through C3
reconstruc0on (gray scale). Density
inside the lumen presumably
corresponding to TMP is indicated with
the yellow arrow. Scale bar = 100Å. (C)
The Tal density alone, viewed from the
side and boNom. The disordered density
at the boNom in the side view is
assumed to be the Tal CTD and was
removed from the boNom view for
clarity. (D) Ribbon representa0on of the
atomic model of Tal viewed from the
side and boNom. One subunit is colored
dark gray. The TMP model is shown in
green. (E) Tal subunit, colored in rainbow
colors from blue (N-terminus) to red (C-
terminus). Relevant structural elements
are labeled. (F) Density corresponding to
the central part of Tal with the atomic
models of Tal and TMP shown in pink
and green, respec0vely. (G) View down
the axis of the baseplate showing the
inside of Tal as a van der Waals surface,
colored from hydrophilic (tan) to
hydrophobic (purple). TMP is shown in
green. (H) Detail of the interac0on
between the TMP C-terminus and Tal.
The three C-terminal residues of TMP
(Y1152, Y1153 and L1154) are shown in
s0ck representa0on.
Figure 6: Examples of segmenting a figure into subfig-
ures and aligning them with subcaption text
with text in its caption or referring context (main
body text referring to the figure). In this way, a
figure can be coarsely attached to an KG entity if
the entity is mentioned in the associated text.
To further delineate semantic and visual infor-
mation contained in each subfigure, we have de-
veloped a pipeline to segment individual subfig-
ures and then align each subfigure with its corre-
sponding sub-caption. We employ Figure-separator
(Tsutsui and Crandall, 2017) to detect and separate
all non-overlapping image regions. Meanwhile,
subfigures in a figure are typically marked with
alphabetical letters (e.g., A, B, C, etc). We use
deep neural networks (Zhou et al., 2017) to detect
text in the figures and use OCR tools (Smith, 2007)
to automatically recognize text information within
each figure. To distinguish subfigure marker text
from text labels in figures to annotate figure con-
tent, we use location proximity between text labels
and subfigures to locate subfigure text markers. Lo-
cation information of such text markers can also be
used to merge multiple image regions into a single
subfigure. At the end, each subfigure is segmented,
and associated with its corresponding subcaption
Figure 7: Expanding knowledge graph through subfig-
ure segmentation and cross-modal entity grounding.
and referring context.
The segmented subfigures and associated text
labels provide rich information that can be used
to expand KG constructed from text captions. For
example, as shown in Figure 7, we apply a classifier
to detect subfigure images those contain molecular
structures. Then by linking specific drug names
extracted from within-figure text to the drug entity
in the coarse KG constructed from the caption text,
a cross-modal expanded KG can be constructed
that links specific molecular structure images to
corresponding drug entities in the KG.
2.4 Knowledge Graph Semantic
Visualization
In order to enhance the exploration and discovery
of the information mined from the COVID-19 liter-
ature through the algorithms discussed in previous
sections, we have been developing techniques to
create semantic visualizations over large datasets of
complex networks of biomedical relations. Seman-
tic visualization allows for visualization of user-
defined subsets of these relations through interac-
tive semantically typed tag clouds and heat maps.
This allows researchers to get a global view of se-
lected relation subtypes drawn from hundreds or
thousands of papers at a single glance. This in turn
allows for the ready identification of novel relation-
ships that would typically be missed by directed
keyword searches or simple unigram word cloud
or heatmap displays.6
We first build a data index from the datasets, and
then create a Kibana dashboard out of the gener-
ated data indices. Each Kibana dashboard has a
collection of visualizations that are designed to in-
teract with each other. Dashboards are fulfilled as
web applications. The navigation of a dashboard is
mainly through clicking and searching. By click-
6https://www.semviz.org/
ing the protein keyword EIF2AK2 in the tag cloud
named “Enzyme proteins participating Modifica-
tion relations”, a constraint on the type of proteins
in modifications is added. Correspondingly, all the
other visualizations will be changed.
One unique feature of the SemViz semantic vi-
sualization is the creation of dense tag clouds and
dense heatmaps, through a process of parameter
reduction over relations, allowing for the visual-
ization of a relation sets as tag clouds and multi-
ple chained relations as heatmaps. Figure 8 illus-
trates such a dense heatmap, where a functionally
typed protein is implicated in a disease relation
(e.g., “those proteins that are down regulators of
INF which are implicated in obesity”).
3 Knowledge-driven Question
Answering
3.1 KG Matching and Path Ranking
With the constructed knowledge graphs from mas-
sive updated scientific literature and domain knowl-
edge, we can support many biomedical hypothe-
sis related queries and inference tools for working
scientists and clinicians. Current question answer-
ing (QA) methods usually rely on word-level or
sentence-level semantic meaning matching. The
questions from existing shared tasks are limited to
non-experts (e.g., Corona Virus Update?) or too
high-level (e.g., What is known about transmission,
incubation, and environmental stability?). Most of
current QA systems are trained from Wikipedia
articles, and thus they will not be effective for
the COVID-19 domain where most answers are
not explicitly written in a single sentence or docu-
ment. In sharp contrast, we develop a QA compo-
nent based on a combination of knowledge graph
matching and distributional semantic matching. It
provides fast and effective answering of questions
about drugs, diseases, chemical entities and genes
from any angle. We build knowledge graph index-
ing and searching functions to facilitate users to
pose queries to search effectively and efficiently.
We also support semantic matching from the con-
structed KGs and related texts by accepting multi-
hop queries.
A common category of queries is about the con-
nections between two entities. Given two entities
as query, we generate a subgraph covering salient
paths between them to show how they are con-
nected through other entities. Figure 3 is an exam-
ple subgraph summarizing the connections between
Figure 8: Regulatory Processes-Disease Interactions Heatmap
Losartan and cathepsin L pseudogene 2. The paths
are generated by traversing the constructed KG,
and are ranked the frequency of paths in the KG.
We construct a subgraph for each query by merg-
ing the paths of top ranked paths. Each edge is
assigned a salience score by aggregating the scores
of paths passing through it,
3.2 Knowledge-driven Sentence Matching
In addition to knowledge elements, we also present
related sentences as evidence. We use BioBert (Lee
et al., 2020) pre-trained language model to repre-
sent each sentence along with its left and right
neighboring sentences as local contexts. Using the
same architecture computed on all respective sen-
tences and user query, we aggregate the sequence
embedding layer, the last hidden layer in the BERT
architecture with average pooling (Reimers and
Gurevych, 2019). We use the similarity between
the embedding representations of each sentence
and query to extract the most relevant sentences as
evidence. Table 1 shows some answer examples
from our QA component.
Question # of Answers Example Answers
Which genes are related
to COVID-19?
687 AP2 associated kinase 1,
myeloperoxidase, thiore-
doxin
Which chemicals are re-
lated to COVID-19?
3,142 acetoacetic acid, Chlo-
rine, Zymosan
Which genes are related
to COVID-19 that can be
transferred from its simi-
lar diseases?
2,168 DEK proto-oncogene,
neclear receptor corepres-
sor 1
Which chemicals are re-
lated to COVID-19 that
can be transferred from
its similar diseases?
327 Ampicillin, Quercetin,
Zoledronic Acid
Table 1: Knowledge-driven QA Output Examples
3.3 Evidence Mining
Queries also often include entity types instead of
entity instances, which requires us to extract evi-
dence sentences based on type or pattern match-
ing. We have developed EVIDENCEMINER (Wang
et al., 2020b,c), a web-based system that allows
a users query as a natural language statement
or an inquired relationship at the meta-symbol
level (e.g., CHEMICAL, PROTEIN) and automati-
cally retrieves textual evidence from a background
corpora of COVID-19. It is supported by data-
driven methods for distantly supervised named en-
tity recognition (Wang et al., 2020d) and pattern-
based open information extraction (Wang et al.,
2018a; Li et al., 2018). The entities and patterns
are pre-computed and indexed offline to support
fast online evidence retrieval. For example, in Fig-
ure 9, the top results of EVIDENCEMINER for the
query (“SARS-COV-2”, “Losartan”) indicates that
“Losartan” can be a potential drug treatment for
“COVID-19”. EVIDENCEMINER achieves better
performance compared with baseline methods such
as BM25 (Robertson et al., 2009) and LitSense
(Allot et al., 2019).
4 A case study on Drug Repurposing
Report Generation
4.1 Task and Data
A human written report about drug repurposing
usually includes answers for the following typical
questions.
1. Current indication: what is the drug class?
What is it currently approved to treat?
2. Molecular structure (symbols desired, but a
pointer to a reference is also useful)
Figure 9: Top results of EvidenceMiner for the query
(“SARS-COV-2”, “Losartan”).
3. Mechanism of action i.e. inhibits viral entry,
replication, etc (w/ a pointer to data)
4. Was the drug identified by manual or compu-
tation screen?
5. Who is studying the drug? (Source/lab name)
6. In vitro Data available (cell line used, assays
run, viral strain used, cytopathic effects, toxi-
city, LD50, dosage response curve, etc)
7. Animal Data Available (what animal model,
LD50, dosage response curve, etc)
8. Clinical trials on going (what phase, facility,
target population, dosing, intervention etc)
9. Funding source
10. Has the drug shown evidence of systemic tox-
icity?
11. List of relevant sources to pull data from.
We use three drugs suggested by DARPA biol-
ogists as case studies: Benazepril, Losartan, and
Amodiaquine. Our KG results for many other drugs
are visualized at our website7. We use the follow-
ing list of chemicals/genes related to COVID-19,
suggested by DARPA biologists:
• BM1 00870 BM1 06175 BM1 16375 BM1 17125
BM1 22385 BM1 30360 BM1 33735 BM1 56245
BM1 56735 BM1 00870 BM1 06175 BM1 16375
BM1 17125 BM1 22385 BM1 30360 BM1 33735
BM1 56245 BM1 56735 CATB-10270 CATB-1418
CATB-1674 CATB-16A CATB-16D2 CATB-1852
CATB-1874 CATB-2744 CATB-3098 CATB-348
CATB-3483 CATB-5880 CATB-84 CATB-912 CATD
CATHY CATK CATL CATL-LIKE CTS12 CTS3
CTS6 CTS7 CTS7-PS CTS8 CTS8L1 CTS8-PS
CTSA CTSA.L CTSB CTSBA CTSBB CTSB.L
CTSB-PS CTSB.S CTSC CTSC.L CTSC.S CTSD
CTSD2 CTSD.S CTSE CTSEAL CTSE.L CTSE.S
CTSF CTSF.L CTSG CTSH CTSH.L CTSH-PS
7http://blender.cs.illinois.edu/
covid19/visualization.html
CTSJ CTSK CTSK1 CTSK.L CTSL CTSL.1 CTSL3
CTSL3P CTSLA CTSLB CTSLL CTSL.L CTSLL3
CTSLP1 CTSLP2 CTSLP3 CTSLP4 CTSLP6
CTSLP8 CTSM CTSM-PS CTSM-PS2 CTSO
CTSO.L CTSQ CTSQL2 CTSR CTSS CTSS1
CTSS.2 CTSS2.1 CTSS2.2 CTSSL CTSS.L CTSS.S
CTSV CTSV.L CTSW CTSW.L CTSZ CTSZ.L
CTSZ.S LOAG 18685 SMP 013040.1 SMP 034410.1
SMP 067050 SMP 067060 SMP 085010 SMP 085180
SMP 103610 SMP 105370 SMP 158410 SMP 158420
SMP 179950 TSP 01409 TSP 02382 TSP 02383
TSP 03306 TSP 07747 TSP 10129 TSP 10493
TSP 11596 LMAN1 LMAN1L LMAN1.L LMAN1.S
LMAN2 LMAN2L MBL1P MBL2 ACE2 FURIN
TMPRSS2
With the knowledge discovered and more pa-
pers about this topic published every day, we need
to keep up to date with the latest development.
For this purpose, we download new COVID-19
papers on a daily basis from three Application
Programming Interfaces (APIs): NCBI PMC API,
NCBI Pubtator API and CORD-19 archive. We
provide incremental updates including new papers,
removed papers and updated papers, and their meta-
data information at our website8.
4.2 Results
Up to June 14, 2020 we have collected 140K
papers. We choose 25,534 peer-reviewed pa-
pers and construct the KG. The current KG in-
cludes 7,230 Diseases, 9,123 Chemicals and 50,864
genes, 1,725,518 chemical-gene links, 5,556,670
chemical-disease links, and 7,7844,574 gene-
disease links. The KG has got more than 800+
downloads.
Several clinicians and medical school students
in our team have manually reviewed the drug repur-
posing reports for three drugs, and also the knowl-
edge graphs connecting 41 drugs and COVID-19
related chemicals/genes. Preliminary results show
that most of our output are informative, valid and
sound. For instance, after the coronavirus enters
the cell in the lungs, it can cause a severe dis-
ease called Acute Respiratory Distress Syndrome
(ARDS). This condition causes the release of in-
flammatory molecules in the body named cytokines
such as Interleukin-2, Interleukin-6, Tumor Necro-
sis Factor, and Interleukin-10. We see all of these
connections in our results, such as the examples
shown in Figure 3 and Figure 10. Some results
are a little surprising to scientists and they think
it’s worth further investigation. For example, in
8http://blender.cs.illinois.edu/
covid19/
lopinavir-ritonavir
drug combination
cathepsin D
COVID-19
Coronavirus
Infections
Severe
Acute
Respiratory
Syndrome
Figure 10: Connections Involving Coronavirus Related
Diseases
Figure 3 we can see that Lusartan is connected to
tumor protein p53 which is related to lung cancer.
Our final generated reports9 are shared publicly.
For each question, our framework provides an-
swers along with detailed evidences, knowledge
subgraphs and image segmentation and analysis
results. Table 2 shows some example answers.
Question Example Answers
Q1
Drug Class angiotensin-converting enzyme (ACE) inhibitors
Disease hypertension
Evidence
[PMID:32314699 (PMC7253125)] Past medical his-
tory was significant for hypertension, treated with
amlodipine and benazepril, and chronic back pain.
Sentences [PMID:32081428 (PMC7092824)] On the other
hand, many ACE inhibitors are currently used to
treat hypertension and other cardiovascular diseases.
Among them are captopril, perindopril, ramipril,
lisinopril, benazepril, and moexipril.
Q4
Disease COVID-19
Evidence
[PMID:32081428 (PMC7092824)] By using a
molecular docking approach, an earlier study iden-
tified N-(2-aminoethyl)-1 aziridine-ethanamine as a
novel ACE2 inhibitor that effectively blocks the
SARS-CoV RBD-mediated cell fusion.
Sentences This has provided a potential candidate and lead
compound for further therapeutic drug development.
Meanwhile, biochemical and cell-based assays can
be established to screen chemical compound libraries
to identify novel inhibitors.
Q6
Disease cardiovascular disease
Evidence
[PMID:22800722 (PMC7102827)] The in vitro half-
maximal inhibitory concentration (IC50) values of
food-derived ACE inhibitory peptides are about 1000
Sentences fold higher than that of synthetic captopril but they
have higher in vivo activities than would be expected
from their in vitro activities.....
Q8
Disease COVID-19
Evidence
[PMID:32336612 (PMC7167588)] Two trials of
losartan as additional treatment for SARS-CoV-2 in-
fection in hospitalized (NCT04312009) or not hos-
pitalized (NCT04311177) patients have been an-
nounced, supported by the background of the huge
adverse impact of the ACE Angiotensin II AT1 re-
ceptor axis over-activity in these patients.
Sentences [PMID:32350632 (PMC7189178)] To address the
role of angiotensin in lung injury, there is an ongoing
clinical trial to examine whether losartan treatment
affects outcomes in COVID-19 associated ARDS
(NCT04312009).
[PMID:32439915 (PMC7242178)] Losartan was
also the molecule chosen in two trials recently started
in the United States by the University of Minnesota
to treat patients with COVID-19 (clinical trials.gov
NCT04311177 and NCT 104312009).
Table 2: Example Answers for Questions in Drug Re-
purposing Reports
9http://blender.cs.illinois.edu/
covid19/DrugRe-purposingReport_V2.0.docx
5 Related Work
There has been a lot of previous work on extract-
ing biomedical entities (Krallinger et al., 2013; Lu
et al., 2015; Leaman and Lu, 2016; Habibi et al.,
2017; Crichton et al., 2017; Wang et al., 2018b;
Beltagy et al., 2019; Alsentzer et al., 2019; Wei
et al., 2019; Wang et al., 2020d), relations (Uzuner
et al., 2011; Krallinger et al., 2011; Segura-Bedmar
et al., 2013; Bui et al., 2014; Peng et al., 2016; Wei
et al., 2015; Peng et al., 2017; Quirk and Poon,
2016; Luo et al., 2017; Wei et al., 2019; Peng et al.,
2019, 2020), and events (Ananiadou et al., 2010;
Van Landeghem et al., 2013; Ne´dellec et al., 2013;
Dele´ger et al., 2016; Wei et al., 2019; Li et al.,
2019; ShafieiBavani et al., 2020) from biomed-
ical corpora to construct KGs. Recently, Hope
et al. (2020); Ilievski et al. (2020); Wolinski (2020);
Ahamed and Samad (2020) build KGs based on
CORD-19 (Wang et al., 2020a).
Most of the recent biomedical QA work is
driven by the BioASQ initiative (Tsatsaronis et al.,
2015) with many algorithms developed (Yang et al.,
2015, 2016; Chandu et al., 2017; Kraus et al.,
2017). There are COVID-19 question answering
live systems coming from BioASQ (COVIDASK10,
AUEB11), and search engines (Kricka et al., 2020;
Esteva et al., 2020; Hope et al., 2020; Taub Tabib
et al., 2020) have also been built. Our work ad-
vances state-of-the-art by extending the knowledge
elements to more fine-grained types, incorporating
image analysis and cross-media knowledge ground-
ing, and knowledge graph matching into question
answering.
6 Conclusions and Future Work
We have developed a novel framework COVID-
KG that automatically transforms massive scien-
tific literature corpus into organized, structured and
actionable knowledge graphs. With COVID-KG,
researchers and clinicians are able to obtain trust-
worthy and non-trivial answers from scientific liter-
ature, and thus focus on more important hypothesis
testing, and prioritize the analysis efforts for can-
didate exploration directions. In our ongoing work
we have created a new ontology that includes 77
entity subtypes and 58 event subtypes, and we are
re-building an end-to-end joint neural IE system
following this new ontology. In the future we plan
to extend COVID-KG to automate the creation of
10https://covidask.korea.ac.kr/
11http://cslab241.cs.aueb.gr:5000/
new hypotheses by predicting new links. Inspired
from our recent success at multimedia event extrac-
tion (Li et al., 2020), we will create a multimedia
common semantic space for literature and apply
it to improve cross-media knowledge grounding,
inference and transfer.
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